Overview
Oligodendroblastoma is a rare, slow-growing tumor originating from oligodendroglial cells, typically found in the central nervous system, often presenting as a well-differentiated neoplasm with low proliferative potential 1.Diagnosis
Imaging studies (MRI) essential for initial characterization and localization 1.
Histopathological examination with immunohistochemistry confirming oligodendroglial differentiation critical 1.
MIB-1 labeling index used for grading proliferation activity 1.
Genetic testing for IDH mutations and 1p/19q codeletion may aid in diagnosis and prognosis 1.Management
Surgical resection is the primary treatment modality aiming for complete removal 1.
Adjuvant radiotherapy considered for residual disease or incomplete resection 1.
Chemotherapy typically reserved for recurrent or aggressive cases; temozolomide may be considered based on molecular profile 1.Special Populations
Limited data available; management generally follows adult protocols with tailored surgical approaches for pediatric cases 1.
Elderly patients may require individualized treatment plans considering comorbidities and functional status 1.
Pregnancy complicates treatment; deferring aggressive interventions until postpartum period is often recommended 1.Key Recommendations
Perform MRI and confirm diagnosis with histopathological examination including immunohistochemistry for definitive diagnosis (Evidence: Expert opinion 1).
Prioritize maximal safe surgical resection for optimal outcomes (Evidence: Expert opinion 1).
Consider adjuvant radiotherapy for incomplete resection or residual disease (Evidence: Expert opinion 1).References
1 Merrill WH. What is in the Dash? An Examination of the Life and Contributions of John B. Flege, Jr., MD. The heart surgery forum 2021. link